Chemoprophylaxis and HAART Therapy in Botswana

Chemoprophylaxis and HAART Therapy in Botswana

Bibliographic Details
Main Author:	Essex M
Format:	Article
Language:	English
Published:	BMC 2005-12-01
Series:	Retrovirology

Similar Items

Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.
by: Kathy Lawler, et al.
Published: (2011-02-01)

High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.
by: Roger L Shapiro, et al.
Published: (2012-01-01)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
by: Manuel L. Fernandez Guerrero, et al.
Published: (2007-09-01)

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)

A comparison of treatment response in two cohorts of once daily HAART and twice daily HAART in a sample population in Gaborone, Botswana
by: Seleke, Rachel
Published: (2013)

Chemoprophylaxis of Tropical Infectious Diseases
by: William J. H. McBride
Published: (2010-05-01)

Review of chemoprophylaxis in leprosy contacts
by: Sergio Souza Cunha
Published: (2014-09-01)

Chemoprophylaxis and Malaria Death Rates
by: Gérard Krause, et al.
Published: (2006-03-01)

Pre-exposure chemoprophylaxis for HIV: It is time
by: Smith Stephen M
Published: (2004-07-01)

Rethinking Chemoprophylaxis for Total Ankle Replacement
by: Adam J. Farrier MBChB, et al.
Published: (2016-08-01)

Tolerability of antiretroviral therapy (HAART) in elderly age
by: Celesia B M
Published: (2010-05-01)

Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention
by: Clauson KA, et al.
Published: (2009-03-01)

Tuberculosis in children – from diagnostics to chemoprophylaxis and treatment
by: Joanna Kosińska, et al.
Published: (2014-06-01)

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy
by: Duthie MS, et al.
Published: (2016-04-01)

Effectiveness study on aspirin chemoprophylaxis in patients with diabetes
by: Cheng-Ching Lin, et al.
Published: (2015)

Features of Early Diagnosis, Causal Treatment and Chemoprophylaxis of Influenza
by: O.M. Zinchuk, et al.
Published: (2013-11-01)

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++
by: Liesbeth F Mieras, et al.
Published: (2018-10-01)

Nephrotoxicity of HAART
by: Robert Kalyesubula, et al.
Published: (2011-01-01)

HAART (Highly Active Anti-Retroviral Therapy) : An overview
by: Praful Pande, et al.
Published: (2014-01-01)

Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis
by: Nevin Remington L
Published: (2009-08-01)

Determining utility values related to malaria and malaria chemoprophylaxis
by: Coyle Doug, et al.
Published: (2010-04-01)

Chemoprophylaxis in sexually transmitted HIV/AIDS lung diseases
by: Venu K
Published: (2006-01-01)

A Systematic Review of Economic Evaluations of Chemoprophylaxis for Tuberculosis
by: Shraddha Chavan, et al.
Published: (2011-01-01)

Invasive Group A Streptococcal Disease: Management and Chemoprophylaxis
by: UD Allen, et al.
Published: (2010-01-01)

Antiviral Resistance and Dynamic Treatment and Chemoprophylaxis of Pandemic Influenza
by: Paz, Sandro
Published: (2014)

Current principles in the chemoprophylaxis of acute respiratory viral infections
by: A A Shul'diakov, et al.
Published: (2013-11-01)

Tuberculosis chemoprophylaxis in rheumatoid arthritic patients receiving tumor necrosis factor inhibitors or conventional therapy
by: Saad Rabie Samra, et al.
Published: (2015-01-01)

Quimioprofilaxia na prevenção da tuberculose Chemoprophylaxis in the prevention of tberculosis
by: Norma I Soza Pineda, et al.
Published: (2004-08-01)

Effects of HIV Infected and HAART Therapies on the Risk of Cardiovascular Disease
by: Wen-Chi Chiu, et al.
Published: (2018)

Factors that influence adherence to highly active antiretroviral therapy (HAART).
by: Naicker, Michaela Helene.
Published: (2013)

Behavioural interventions to enhance Highly Active Retroviral Therapy (HAART)
by: Loggerenberg, Francois van
Published: (2011)

Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
by: Hatz Christoph, et al.
Published: (2010-09-01)

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
by: B G Manjunath, et al.
Published: (2020-01-01)

The role of rifaximin in the treatment and chemoprophylaxis of travelers&#39; diarrhea
by: Hoonmo L Koo, et al.
Published: (2009-10-01)

Antiamoebic Chemoprophylaxis Using Quinfamide in Children: A Comparative Study
by: Nicolas Padilla, et al.
Published: (2002-01-01)

The importance of chemoprophylaxis in tuberculosis: On occasion of eight cases in the same family
by: Mahşuk Taylan, et al.
Published: (2013-12-01)

Chemoprophylaxis for Venous Thromboembolism Prevention: Concerns Regarding Efficacy and Ethics
by: Eric Swanson, MD
Published: (2013-06-01)

Malaria Chemoprophylaxis for Travelers: The Knowledge of Physicians in the State of Qatar, 2017
by: Ahmad Bawazir, et al.
Published: (2018-05-01)

Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.
by: Ludovic Reveiz, et al.
Published: (2011-01-01)

Chemoprophylaxis in the prevention of Clostridium difficile infection: Still a ways to go
by: M. Tobar-Marcillo, et al.
Published: (2017-10-01)